Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Chiang

Showing results (231-240 of 449) with videos related to

Pageof 45
Sort By:
Drugs Under Experimental and Clinical Research|January 1, 1985
Experimental efficacy and pharmacokinetic properties of cefpiramide, a new cephalosporinK P Fu, T Vince, S McCloud, et al.
Biointerphases|July 3, 2014
Natural zwitterionic organosulfurs as surface ligands for antifouling and responsive propertiesChun-Jen Huang, Lin-Chuan Wang, Chia-Yu Liu, et al.
Revista Medica De Chile|January 29, 1999
[Lipids, lipoproteins and apolipoproteins in normal newborns]V Casanueva, X Cid, M T Chiang, et al.
Chemical Communications (Cambridge, England)|February 19, 2005
Facile synthesis of stable cubic mesoporous silica SBA-1 over a broad temperature range with the aid of D-fructoseHsien-Ming Kao, Chun-Chiang Ting, Anthony S T Chiang, et al.
Journal of Clinical Pharmacology|August 1, 1996
Population pharmacokinetics of intravenous amiodarone in patients with refractory ventricular tachycardia/fibrillationJ M Korth-Bradley, G M Rose, P J de Vane, et al.
The American Journal of Cardiology|February 17, 2001
Bioavailability of amiodarone tablets administered with and without food in healthy subjectsX Meng, P Mojaverian, M Doedée, et al.
Journal of Gastroenterology and Hepatology|May 1, 1995
Haemodynamic effects of enalaprilat on portal hypertension in patients with HBsAg-positive cirrhosisH T Chiang, J S Cheng, M Lin, et al.
Revista Medica De Chile|July 1, 1996
[Lipoprotein in children and adolescents: relationship with family history of coronary artery disease]V Casanueva, X Cid, C Calvo, et al.
Journal of Clinical Pharmacology|August 1, 1992
Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metaboliteK J Klamerus, K Maloney, R L Rudolph, et al.
Drug and Alcohol Dependence|October 21, 1999
Naltrexone shortened opioid detoxification with buprenorphineA Umbricht, I D Montoya, D R Hoover, et al.
Pageof 45

Showing results (231-240 of 449) with videos related to

Sort By:
Pageof 45
Drugs Under Experimental and Clinical Research|January 1, 1985
Experimental efficacy and pharmacokinetic properties of cefpiramide, a new cephalosporinK P Fu, T Vince, S McCloud, et al.
Biointerphases|July 3, 2014
Natural zwitterionic organosulfurs as surface ligands for antifouling and responsive propertiesChun-Jen Huang, Lin-Chuan Wang, Chia-Yu Liu, et al.
Revista Medica De Chile|January 29, 1999
[Lipids, lipoproteins and apolipoproteins in normal newborns]V Casanueva, X Cid, M T Chiang, et al.
Chemical Communications (Cambridge, England)|February 19, 2005
Facile synthesis of stable cubic mesoporous silica SBA-1 over a broad temperature range with the aid of D-fructoseHsien-Ming Kao, Chun-Chiang Ting, Anthony S T Chiang, et al.
Journal of Clinical Pharmacology|August 1, 1996
Population pharmacokinetics of intravenous amiodarone in patients with refractory ventricular tachycardia/fibrillationJ M Korth-Bradley, G M Rose, P J de Vane, et al.
The American Journal of Cardiology|February 17, 2001
Bioavailability of amiodarone tablets administered with and without food in healthy subjectsX Meng, P Mojaverian, M Doedée, et al.
Journal of Gastroenterology and Hepatology|May 1, 1995
Haemodynamic effects of enalaprilat on portal hypertension in patients with HBsAg-positive cirrhosisH T Chiang, J S Cheng, M Lin, et al.
Revista Medica De Chile|July 1, 1996
[Lipoprotein in children and adolescents: relationship with family history of coronary artery disease]V Casanueva, X Cid, C Calvo, et al.
Journal of Clinical Pharmacology|August 1, 1992
Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metaboliteK J Klamerus, K Maloney, R L Rudolph, et al.
Drug and Alcohol Dependence|October 21, 1999
Naltrexone shortened opioid detoxification with buprenorphineA Umbricht, I D Montoya, D R Hoover, et al.
Pageof 45